Cargando…
Early Direct Antiglobulin Test Negativity after Bendamustine and Rituximab Treatment in Chronic Lymphocytic Leukemia: Two Cases
Autores principales: | Eren, Rafet, Suyanı, Elif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256830/ https://www.ncbi.nlm.nih.gov/pubmed/29983407 http://dx.doi.org/10.4274/tjh.2017.0464 |
Ejemplares similares
-
Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives
por: Sriwijitalai, Won, et al.
Publicado: (2019) -
Interference in the indirect antiglobulin test and direct
antiglobulin test from rheumatoid factor
por: Xu, Lei, et al.
Publicado: (2019) -
Severe hemolysis with negative direct antiglobulin test: A case report
por: Behzadifard, Mahin, et al.
Publicado: (2022) -
Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
por: Coutre, Steven E., et al.
Publicado: (2018) -
A Primary Bone Diffuse Large B-Cell Lymphoma with Ocular Adnexal Involvement
por: Eren, Rafet, et al.
Publicado: (2016)